Search Within

Joachim Yahalom

  1. "Andrew Zelenetz"
Formats
  1. Journal Article (57)
  2. Meeting Abstract (56)
  3. Research Letter (3)
Groups
  1. Center for Hematologic Malignancies (116)
  2. Department of Medicine (116)
  3. Hematologic Malignancies, Division of (116)
  4. Lymphoma (116)
  5. Radiation Oncology, Department of (116)
  6. Survivorship Research (116)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Craig Moskowitz (62)
  3. Ariela Noy (60)
  4. Steven Horwitz (60)
  5. David Straus (59)
  6. Paul Hamlin (53)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (11)
  4. 2022 (3)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Blood (49)
  2. Journal of the National Comprehensive Cancer Network (14)
  3. Hematological Oncology (9)
  4. Journal of Clinical Oncology (9)
  5. British Journal of Haematology (7)
  6. Blood Advances (5)

More Publications

Publishers
  1. American Society of Hematology (54)
  2. Harborside Press (14)
  3. American Society of Clinical Oncology (9)
  4. Wiley Blackwell (9)
  5. John Wiley & Sons (7)
  6. Elsevier Inc. (5)

More Publishers

Results (116)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Glassman, J. R.; Portlock, C. S.; Yahalom, J.; Straus, D. J.; O'Brien, J. P.; Elkin, N.; Bertino, J. R.; Zelenetz, A. D.
    Bone Marrow Transplantation (1999)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose therapy and peripheral blood progenitor cell transplantation (HDT/PBPCT) in patients with non-Hodgkin's lymphoma (NHL) over the age of 55 years
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Childs, B.; Frank, R.; Malhotra, S.; Coady-Lyons, N.; Yahalom, J.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save
  • NCCN preliminary non-Hodgkin's lymphoma practice guidelines
    Journal Article

    Shipp, M. A.; Ambinder, R. F.; Appelbaum, F. R.; Cabanillas, F.; Harris, N. J.; Herzig, G. P.; Hoppe, R. T.; Horning, S. J.; Pezner, R. D.; Rodriguez, M. A.; more...
    Oncology (Norwalk) (1997)

    Fulltext@MSK | Save
  • Autologous bone marrow transplantation following high-dose chemotherapy with or without accelerated hyperfractionated total lymphoid irradiation for patients with refractory or relapsed Hodgkin's disease
    Meeting Abstract

    Moni, J.; Yahalom, J.; Bertino, J.; O'Brien, J.; Portlock, C.; Straus, D.; Zelenetz, A.; Gomez, E.; Gulati, S.
    International Journal of Radiation Oncology, Biology, Physics (1995)

    Fulltext@MSK | Save